Indefinite Delivery Contract SPE2DU25D9332

The federal contract IDV is a $4,999,999 single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The IDC covers a wide range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

The original solicitation outlines plans for DLA Troop Support to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The solicitation is expected to be issued in March 2024 and will be an unrestricted, fully competitive acquisition awarded on a Lowest Price Technically Acceptable (LPTA) basis, with the potential use of reverse auctions to obtain the best distribution fees from primary and backup suppliers.